Search for Clinical Trial Results
Localized Scleroderma - 18 Studies Found
Status | Study |
Recruiting |
Study Name: Fractional Carbon Dioxide Laser Versus UVA 1 in Treatment of Localized Scleroderma Condition: Localized Scleroderma Date: 2013-09-05 Interventions:
|
Withdrawn |
Study Name: Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study Condition: Morphea Date: 2005-09-28 Interventions: Drug: imiquimod 5% cream (Aldara) |
Terminated |
Study Name: Molecular Effects of Topical Calcipotriene on Morphea Condition:
Date: 2015-03-03 Interventions: Drug: topical calcipotriene 0.005% ointment Affected area will be treated twice daily for 3 months |
Completed |
Study Name: Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea. Condition: Symmetric Limited Morphea. Date: 2008-12-18 Interventions:
|
Completed |
Study Name: Imiquimod in Children With Plaque Morphea Condition: Scleroderma, Localized Date: 2005-09-02 Interventions: Drug: Imiquimod 5% cream Treatment will last for 36 weeks. Patients will be instructed to apply Imiquimo |
Completed |
Study Name: Treatment Study Comparing UVA-1 Phototherapy Versus Placebo Treatment for Morphea Condition:
Interventions: |
Completed |
Study Name: Efficacy and Safety of Imatinib in Scleroderma Condition:
Date: 2007-05-29 Interventions: Drug: imatinib mesylate 6 month treatment with 400mg/day (per os) |
Withdrawn |
Study Name: Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea Condition: Scleroderma Date: 2016-02-09 Interventions:
|
Recruiting |
Study Name: The Effect of Ethanol Extract Physalis Angulata Linn in Scleroderma Patients With Standard Therapy Condition: Scleroderma Date: 2016-06-20 Interventions:
|
Recruiting |
Study Name: The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma) Condition: Scleroderma Date: 2015-02-03 |